This content is machine translated Diabetes mellitus type 2 New Swiss guidelines support cardiovascular disease control The treatment of type 2 diabetes mellitus has undergone a transformation in recent years with the approval of new drug classes. The focus is no longer on pure glycemic control,…
View Post 4 min This content is machine translated Diabetes Cases Cardio-renal prevention: the revolution in diabetes management in 2020 A 68-year-old patient with type 2 diabetes mellitus is undergoing cardiac rehabilitation after a myocardial infarction. Despite antidiabetic treatment, his HbA1c value is deteriorating and his weight is steadily increasing. However, with the…
View Post 3 min This content is machine translated Diabetic kidney disease Canagliflozin approved in fast track for diabetic nephropathy Kidney protection is extremely important for diabetes sufferers. Recently, canagliflozin became the first SGLT-2 inhibitor in Switzerland to receive a marketing authorization extension to reduce the risk of progression to…
View Post 3 min This content is machine translated Heart failure in type 2 diabetes Indication expansion for SGLT2 inhibitor and combination preparation Because of the high prevalence and mortality, it is particularly important to protect patients with type 2 diabetes from heart failure as early as possible. The indication expansion of dapagliflozin…
View Post 3 min This content is machine translated Chronic renal failure Dapagliflozin meets primary endpoints ahead of schedule The Phase III DAPA-CKD study will be terminated earlier than planned due to proven efficacy in patients with chronic renal failure. Dapagliflozin is the first SGLT2 inhibitor to show meaningful…
View Post 6 min This content is machine translated Type 2 diabetes: SGED Recommendations 2020 Update Cardiovascular risk stratification and personalized therapy. When prescribing antidiabetic therapy, other criteria are relevant today in addition to blood glucose control. The cardiac benefit of SGLT2 inhibitors and GLP1 analogues has been incorporated into international guidelines…
View Post 11 min This content is machine translated Hypertension in practice High blood pressure – What the family doctor needs to know After a confirmed diagnosis of arterial hypertension, one should assess the severity, overall cardiovascular risk, and any organ damage present. First-line antihypertensives are RAAS blockers alone or combined with Ca…
View Post 7 min This content is machine translated "The lower the better" New AGLA Pocket Guide “Prevention of Atherosclerosis To reduce the risk of cardiovascular disease, low LDL-C levels are critical [1]. This finding is also reflected in the ESC/EAS Dyslipidemia Guidelines – the basis for the new Swiss…
View Post 3 min This content is machine translated Diabetes Cases Management of intolerance to various antidiabetic drugs. A 55-year-old patient, who has had type 2 diabetes mellitus for 15 years, has adverse reactions to a wide variety of antidiabetic drugs that require a change in treatment. In…
View Post 1 min This content is machine translated Diabetes Cases Webcast “Practical Questions on the Current SGED Recommendations 2020” with Prof. Roger Lehmann, M.D. In the webcast, Prof. Lehmann presents the Swiss guidelines for the treatment of type 2 diabetes mellitus , the “most modern and simplest recommendations in the world.” Based on current clinical data,…
View Post 12 min This content is machine translated Medullary thyroid carcinoma Calcitonin as a tumor marker Thyroid nodules are a well-known phenomenon; fortunately, medullary thyroid carcinomas are not. It is a malignant degeneration of the C cells of the thyroid gland, which are located parafollicularly and…
